The AFFIRM-1 Study - Now Enrolling
It’s normal to feel nervous in some social situations - whether speaking in public, meeting new people, or starting a new job. But for millions of adults, these everyday interactions cause severe anxiety, self-consiousness, or avoidance - a condition known as social anxiety disorder (SAD). Social anxiety disorder is more than just shyness - some examples include:
If you get anxious in social situations or being the center of attention, you may qualify for the AFFIRM-1 Study, a new research study being conducted at select centers across the U.S. The study is exploring the effect of an investigational oral medication when used on demand to treat symptoms of social anxiety disorder.
The study lasts about 3 weeks and involves 2 visits to your local study center (you will receive a payment for completing each of these visits). Your first visit, called the Screening Visit, will help determine if you qualify to join the study. If you qualify and wish to continue, you will return for a second visit, the Treatment Visit. At this visit, you will take the study medication and will be asked to complete some questionnaires and other assessments related to your anxiety.
Participants in the AFFIRM-1 Study will receive all study-related care at no cost and will be compensated for their time and travel to attend up to 2 visits over a 3-week period.
See If You Qualify
To see if you might qualify for the AFFIRM-1 Study, and to connect with a local study center to learn more, please take the questionnaire below.